Although the total number of circulating CD8 T cells in peripheral blood may reflect the overall immunologic status, the T cell subtypes involved in cancer immunity are very heterogeneous, and many of them are not tumor-specific [49,50]. This evidence concerns the gene CD8A and cancer.